Dr Matthew Franklin, BA, MSc, PhD
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA
Tel: (+44) (0)114 222 4226
Fax: (+44) (0)114 222 0749
Director of HEDM email: firstname.lastname@example.org
Personal work email: email@example.com
I joined ScHARR in 2014 as a Health Economist Research Associate for HEDS, working in collaboration with the Collaboration for Leadership in Applied Health Research and Care for Yorkshire and Humber (CLAHRC YH). As of January 2017, I have been promoted to the position of Research Fellow. As of July 2018, I am the current Director of the MSc Health Economics and Decision Modelling (HEDM) course.
I completed my BA in Economics and MSc in Economics and Health Economics at the University of Sheffield in 2007 and 2008, respectively. I then moved to the University of Nottingham in 2008, working as a Health Economist Research Associate, as well as starting my PhD in Health Economics in 2010. I completed and passed my Viva for my PhD thesis, titled "The role of utility, health, and capabilities in economic evaluation: a case study in frail older people", as of December 2014.
During my time as a health economist I have provided health economic support for at least five completed Randomised Controlled Trials (RCTs), as well as a number of cohort, pilot and feasibility studies. Although I specialise in the use of routinely collected healthcare data and outcome measures for the purpose of economic evaluations alongside clinical trials, I also have an interest in: (1) the psychometric assessment and statistical analysis of health, well-being and capability-based measures; and (2) the use of routinely collected healthcare resource-use information from large observational datasets or directly from the health or social care service for the purpose of economic analyses, developing economic models, and costing exercises.
1. Use of routinely collected healthcare data for trial-based economic analyses and economic modelling
2. Trial-based economic evaluation and outcome measurement
3. Cost-effectiveness analysis and Markov modelling methodology
4. The capability approach to outcomes measurement and valuation
5. Pathway-based economic modelling
1. Course Director for MSc Health Economics and Decision Modelling (HEDM)
2. Deputy HEDS department lead for the ScHARR Information Governance (IG) committee
- Franklin M, Mukuria C, Mulhern B, Tran I, Brazier J & Watson S (2019) Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity. The Patient - Patient-Centered Outcomes Research, 1-13. View this article in WRRO
- Franklin M, Lomas J, Walker S & Young T (2019) An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis. PharmacoEconomics, 37(5), 631-643. View this article in WRRO
- Franklin M & Thorn J (2019) Self-reported and routinely collected electronic healthcare resource-use data for trial-based economic evaluations: the current state of play in England and considerations for the future. BMC Medical Research Methodology, 19. View this article in WRRO
- Franklin M, Payne K & Elliott RA (2018) Quantifying the Relationship between Capability and Health in Older People: Can’t Map, Won’t Map. Medical Decision Making, 38(1), 79-94. View this article in WRRO
- Franklin M, Davis S, Horspool M, Kua WS & Julious S (2017) Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study. PharmacoEconomics, 35(5), 561-573. View this article in WRRO
- Franklin M, Wailoo A, Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB & Thornhill MH (2016) The Cost-Effectiveness of Antibiotic Prophylaxis for Patients at Risk of Infective Endocarditis. Circulation, 134(20), 1568-1578. View this article in WRRO
- Tanajewski L, Franklin M, Gkountouras G, Berdunov V, Harwood RH, Goldberg SE, Bradshaw LE, Gladman JRF & Elliott RA (2015) Economic Evaluation of a General Hospital Unit for Older People with Delirium and Dementia (TEAM Randomised Controlled Trial). PLOS ONE, 10(12), e0140662-e0140662.
- Tanajewski L, Franklin M, Gkountouras G, Berdunov V, Edmans J, Conroy S, Bradshaw LE, Gladman JRF & Elliott RA (2015) Cost-Effectiveness of a Specialist Geriatric Medical Intervention for Frail Older People Discharged from Acute Medical Units: Economic Evaluation in a Two-Centre Randomised Controlled Trial (AMIGOS). PLoS ONE, 10(5), e0121340.
- Franklin M, Berdunov V, Edmans J, Conroy S, Gladman J, Tanajewski L, Gkountouras G & Elliott RA (2014) Identifying patient-level health and social care costs for older adults discharged from acute medical units in England. Age and Ageing, 43(5), 703-707.
- Elliott RA, Putman KD, Franklin M, Annemans L, Verhaeghe N, Eden M, Hayre J, Rodgers S, Sheikh A & Avery AJ (2014) Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER). PharmacoEconomics, 32(6), 573-590.
- Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R & Gladman JRF (2014) Health status of UK care home residents: a cohort study. Age and Ageing, 43(1), 97-103.
- Edmans J, Bradshaw L, Franklin M, Gladman J & Conroy S (2013) Specialist geriatric medical assessment for patients discharged from hospital acute assessment units: randomised controlled trial. BMJ, 347(oct08 2), f5874-f5874.
- Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Cresswell K, Eden M, Elliott RA, Howard R, Kendrick D, Morris CJ , Prescott RJ et al (2012) A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. The Lancet, 379(9823), 1310-1319.
- Franklin M (2017) Cost Utility Analysis, Mental Health Economics (pp. 89-119). Springer International Publishing
- Berdunov V & Franklin M (2017) Introduction to Statistics and Modeling Methods Applied in Health Economics, Mental Health Economics (pp. 121-153). Springer International Publishing